DISTRIBUTOR AGREEMENTDistributor Agreement • February 17th, 2009 • ALDA Pharmaceuticals Corp. • Pharmaceutical preparations • British Columbia
THIS DISTRIBUTOR AGREEMENT ("Agreement") is entered into and effective as of February 1st, 2005 ("Effective Date") by and between Esthetics Plus Inc., an Alberta limited liability company ("EP") and ALDA Pharmaceuticals Corp., a British Columbia limited liability company ("ALDA").
AGREEMENTAgreement • March 20th, 2006 • ALDA Pharmaceuticals Corp.
NON-COMPETITION AGREEMENTNon-Competition Agreement • December 3rd, 2008 • ALDA Pharmaceuticals Corp. • Pharmaceutical preparations
AVRICORE HEALTH SIGNS MASTER AGREEMENT TO PILOT HEALTHTAB™ PLATFORM FOR DIABETES MANAGEMENT IN SELECT SHOPPERS DRUG MART® PHARMACIESAvricore Health Signs Master Agreement • July 14th, 2021 • Avricore Health Inc. • Pharmaceutical preparations
The program, as per the Master Agreement Statement of Work, will launch in eleven Shoppers Drug Mart locations in Ontario with HealthTab™-integrated Afinion2™ analyzers by Abbott Diagnostics to refine workflow and engagement approaches. Pharmacists will test patients’ average blood sugar (HbA1C) and lipids with results reported via the cloud-based HealthTab™ system.
HEALTHTAB™ SIGNS AGREEMENT FOR MORE REXALL® PHARMACY LOCATIONSHealthtab™ Signs Agreement • May 8th, 2024 • Avricore Health Inc. • Pharmaceutical preparations
VANCOUVER, BC – (GLOBE NEWSWIRE) – April 4, 2024 – Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce further expansion of HealthTab™ with Rexall Pharmacy Group ULC (“Rexall”). The Companies have been working closely to develop the best patient approaches and internal workflows to ensure the most successful deployment of this powerful point-of-care testing platform.
DISTRIBUTORSHIP AGREEMENTDistributorship Agreement • March 20th, 2006 • ALDA Pharmaceuticals Corp. • British Columbia
ALDA PHARMACEUTICALS CORP., a corporation existing under the laws of the Province of British Columbia, Canada and having its principal address at: 635 Columbia Street, New Westminster, BC V3M 1A7 CANADA
PageLease Agreement • March 20th, 2006 • ALDA Pharmaceuticals Corp. • British Columbia
June 18, 2008 Trevor McKee Director of Sales & Marketing, Norwood Packaging Ltd.ALDA Pharmaceuticals Corp. • March 27th, 2009 • Pharmaceutical preparations
Letter of Agreement October 26, 2004Letter of Agreement • March 20th, 2006 • ALDA Pharmaceuticals Corp. • British Columbia
ALDA is the owner of proprietary infection control technology, ALDA wants its products licensed and distributed in China, FUZHOU wants the exclusive right to license and manufacture ALDA’S products in China and FUZHOU wants to distribute ALDA’S products in the Chinese province of Fujian
LETTER OF AGREEMENTLetter of Agreement • March 20th, 2006 • ALDA Pharmaceuticals Corp.
WHEREAS ALDA has developed a disinfectant product known as T36® Disinfectant (“T36D”, also currently known as Viralex) for broad spectrum surface disinfection and
PageLease Agreement • February 8th, 2010 • ALDA Pharmaceuticals Corp. • Pharmaceutical preparations • British Columbia
LETTER OF AGREEMENTLetter of Agreement • December 3rd, 2008 • ALDA Pharmaceuticals Corp. • Pharmaceutical preparations • British Columbia
This Voting Agreement made as of the 13th day of November, 2003 By: ALDA Pharmaceuticals Inc., a company incorporated in the Province of British Columbia And: Dr. Allan Shapiro, of the Municipality of Surrey, in the Province of British Columbia...Voting Agreement • December 3rd, 2008 • ALDA Pharmaceuticals Corp. • Pharmaceutical preparations • British Columbia
Concurrently with the execution and delivery of this Voting Agreement, ALDA is completing the sale of the assets of its business as a going concern to Duft pursuant to an Asset Purchase Agreement made as of the 1st day of September, 2002 among ALDA, Duft and Shapiro, in consideration of Duft paying the Purchase Price of $800,000 to ALDA by issuing to ALDA commons shares in the capital of Duft.
